<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: The risk for <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD)-related <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) remains a matter of debate </plain></SENT>
<SENT sid="1" pm="."><plain>Initial reports mainly originate from tertiary referral centers, and conflict with more recent studies </plain></SENT>
<SENT sid="2" pm="."><plain>Overall, epidemiology of IBD-related <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> is relevant to strengthen the basis of surveillance guidelines </plain></SENT>
<SENT sid="3" pm="."><plain>We performed a nationwide nested case-control study to assess the risk for IBD-related <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and associated prognostic factors in general hospitals </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: IBD patients diagnosed with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> between January 1990 and July 2006 in 78 Dutch general hospitals were identified as cases, using a nationwide automated pathology database </plain></SENT>
<SENT sid="5" pm="."><plain>Control IBD patients without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> were randomly selected </plain></SENT>
<SENT sid="6" pm="."><plain>Clinical data were collected from detailed chart review </plain></SENT>
<SENT sid="7" pm="."><plain>Poisson regression analysis was used for univariable and multivariable analyses </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: A total of 173 cases were identified through pathology and chart review and compared with 393 controls </plain></SENT>
<SENT sid="9" pm="."><plain>The incidence rate of IBD-related <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> was 0.04% </plain></SENT>
<SENT sid="10" pm="."><plain>Risk factors for IBD-related <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> were older age, concomitant primary sclerosing <z:mp ids='MP_0003254'>cholangitis</z:mp> (PSC, relative ratio (RR) per year duration 1.05; 95% confidence interval (CI) 1.01-1.10), <z:e sem="disease" ids="C0032568" disease_type="Disease or Syndrome" abbrv="">pseudopolyps</z:e> (RR 1.92; 95% CI 1.28-2.88), and duration of IBD (RR per year 1.04; 95% CI 1.02-1.05) </plain></SENT>
<SENT sid="11" pm="."><plain>Using immunosuppressive therapy (odds ratio (OR) 0.3; 95% CI 0.16-0.56, P&lt;0.001) or anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF) (OR 0.09; 95% CI 0.01-0.68, P&lt;0.02) was protective </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: We found a limited risk for developing IBD-related <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in The Netherlands </plain></SENT>
<SENT sid="13" pm="."><plain>Age, duration of PSC and IBD, concomitant <z:e sem="disease" ids="C0032568" disease_type="Disease or Syndrome" abbrv="">pseudopolyps</z:e>, and use immunosuppressives or anti-TNF were strong prognostic factors in general hospitals </plain></SENT>
</text></document>